Management of Cushing disease

Nature Reviews Endocrinology

Volumn 7, Issue 5, 2011, Pages 279-289

  Tritos, Nicholas A ^a   Biller, Beverly M K ^a   Swearingen, Brooke ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; BROMOCRIPTINE; CABERGOLINE; CYPROHEPTADINE; DEXAMETHASONE; ETOMIDATE; HYDROCORTISONE; KETOCONAZOLE; LOPERAMIDE; METYRAPONE; MIFEPRISTONE; MITOTANE; OCTREOTIDE; PASIREOTIDE; PIOGLITAZONE; PREDNISOLONE; PREDNISONE; ROSIGLITAZONE; TRILOSTANE; VALPROIC ACID;

ADRENAL DISEASE; ADRENAL INSUFFICIENCY; ADRENALECTOMY; BLEEDING; CANCER RADIOTHERAPY; CLINICAL TRIAL (TOPIC); CUSHING DISEASE; CUSHING SYNDROME; DEEP VEIN THROMBOSIS; DIABETES INSIPIDUS; DIARRHEA; DIZZINESS; DRUG EFFICACY; DYSLIPIDEMIA; EDEMA; ENDOMETRIUM HYPERPLASIA; EPISTAXIS; FETUS WASTAGE; GASTROINTESTINAL SYMPTOM; GYNECOMASTIA; HEMATOMA; HERNIA; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; HYPERCORTISOLISM; HYPERGLYCEMIA; HYPERTENSION; HYPERTRANSAMINASEMIA; HYPOADRENALISM; HYPOKALEMIA; HYPONATREMIA; HYPOPITUITARISM; LATENT PERIOD; LIQUORRHEA; LIVER TOXICITY; MENINGITIS; MORBIDITY; NAUSEA; NELSON SYNDROME; NEUROLOGIC DISEASE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RASH; RECURRENCE RISK; RECURRENT DISEASE; REMISSION; REOPERATION; REVIEW; SEDATION; SIDE EFFECT; SURGICAL TECHNIQUE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; VALVULAR HEART DISEASE; VENOUS THROMBOEMBOLISM; VOMITING;

ADRENALECTOMY; CUSHING SYNDROME; HUMANS; PITUITARY ACTH HYPERSECRETION;

EID: 79955086260     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2011.12     Document Type: Review

References (123)

1. Cushing, H. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull. Johns Hopkins Hosp. 50, 137-195 (1932).
2. Cushing, H. The basophil adenomas of the pituitary body. Ann. R. Coll. Surg. Engl. 44, 180-181 (1969).
3. Nieman, L. K. & Ilias, I. Evaluation and treatment of Cushing's syndrome. Am. J. Med. 118, 1340-1346 (2005). (Pubitemid 41832323)
4. Raff, H. & Findling, J. W. A physiologic approach to diagnosis of the Cushing syndrome. Ann. Intern. Med. 138, 980-991 (2003). (Pubitemid 38129119)
5. Arnaldi, G. et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88, 5593-5602 (2003). (Pubitemid 38033020)
6. Biller, B. M. et al. Treatment of adrenocorticotropin-dependent Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 93, 2454-2462 (2008). (Pubitemid 352008503)
7. Nieman, L. K. et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J. Clin. Endocrinol. Metab. 93, 1526-1540 (2008). (Pubitemid 351656485)
8. Bonneville, J. F., Cattin, F., Bonneville, F., Schillo, F. & Jacquet, G. Pituitary gland imaging in Cushing's disease [French]. Neurochirurgie 48, 173-185 (2002). (Pubitemid 34606331)
9. Dwyer, A. J. et al. Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. Radiology 163, 421-426 (1987). (Pubitemid 17068919)
10. Hardy, J. Excision of pituitary adenomas by transsphenoidal approach [French]. Union Med. Can. 91, 933-945 (1962).
11. Oldfield, E. H. et al. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N. Engl. J. Med. 312, 100-103 (1985). (Pubitemid 15192140)
12. Oldfield, E. H. et al. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N. Engl. J. Med. 325, 897-905 (1991).
13. nd, Klibanski, A. & Swearingen, B. Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the effects of hospital and surgeon volume. J. Clin. Endocrinol. Metab. 88, 4709-4719 (2003). (Pubitemid 37357516)
14. Semple, P. L. & Laws, E. R. Jr. Complications in a contemporary series of patients who underwent transsphenoidal surgery for Cushing's disease. J. Neurosurg. 91, 175-179 (1999).
15. Swearingen, B. et al. Long-term mortality after transsphenoidal surgery for Cushing disease. Ann. Intern. Med. 130, 821-824 (1999). (Pubitemid 29231150)
16. Fitzgerald, P.A. et al. Cushing's disease: transient secondary adrenal insufficiency after selective removal of pituitary microadenomas; evidence for a pituitary origin. J. Clin. Endocrinol. Metab. 54, 413-422 (1982). (Pubitemid 12006620)
17. Ram, Z. et al. Early repeat surgery for persistent Cushing's disease. J. Neurosurg. 80, 37-45 (1994). (Pubitemid 24020703)
18. Patil, C. G. et al. Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. J. Clin. Endocrinol. Metab. 93, 358-362 (2008). (Pubitemid 351246675)
19. Sonino, N., Zielezny, M., Fava, G. A., Fallo, F. & Boscaro, M. Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J. Clin. Endocrinol. Metab. 81, 2647-2652 (1996). (Pubitemid 26240292)
20. Invitti, C. et al. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J. Clin. Endocrinol. Metab. 84, 440-448 (1999). (Pubitemid 29075666)
21. Hammer, G. D. et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J. Clin. Endocrinol. Metab. 89, 6348-6357 (2004). (Pubitemid 39628458)
22. Rollin, G. A., Ferreira, N. P., Junges, M., Gross, J. L. & Czepielewski, M. A. Dynamics of serum Cortisol levels after transsphenoidal surgery in a cohort of patients with Cushing's disease. J. Clin. Endocrinol. Metab. 89, 1131-1139 (2004). (Pubitemid 38368401)
23. Shimon, I., Ram, Z., Cohen, Z. R. & Hadani, M. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Neurosurgery 51, 57-62 (2002). (Pubitemid 36331099)
24. Carrasco, C. A. et al. Midnight salivary Cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease. J. Clin. Endocrinol. Metab. 93, 4728-4734 (2008).
25. Bochicchio, D., Losa, M. & Buchfelder, M. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J. Clin. Endocrinol. Metab. 80, 3114-3120 (1995).
26. Rees, D. A. et al. Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin. Endocrinol. (Oxf.) 56, 541-551 (2002). (Pubitemid 34429630)
27. Chee, G. H., Mathias, D. B., James, R. A. & Kendall-Taylor, P. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin. Endocrinol. (Oxf.) 54, 617-626 (2001). (Pubitemid 34208905)
28. Guilhaume, B. et al. Transsphenoidal pituitary surgery for the treatment of Cushing's disease: results in 64 patients and long term follow-up studies. J. Clin. Endocrinol. Metab. 66, 1056-1064 (1988).
29. Blevins, L. S. Jr, Christy, J. H., Khajavi, M. & Tindall, G. T. Outcomes of therapy for Cushing's disease due to adrenocorticotropin-secreting pituitary macroadenomas. J. Clin. Endocrinol. Metab. 83, 63-67 (1998). (Pubitemid 28498311)
30. Yap, L. B., Turner, H. E., Adams, C. B. & Wass, J. A. Undetectable postoperative Cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clin. Endocrinol. (Oxf.) 56, 25-31 (2002). (Pubitemid 34107318)
31. Dehdashti, A. R. & Gentili, F. Current state of the art in the diagnosis and surgical treatment of Cushing disease: early experience with a purely endoscopic endonasal technique. Neurosurg. Focus. 23, E9 (2007).
32. Zada, G., Governale, L. S. & Laws, E. R. Jr. Intraoperative conversion from endoscopic to microscopic approach for the management of sellar pathology: incidence and rationale in a contemporary series. World Neurosurg. 73, 334-337 (2010).
33. Trainer, P. J. et al. Transsphenoidal resection in Cushing's disease: undetectable serum Cortisol as the definition of successful treatment. Clin. Endocrinol. (Oxf.) 38, 73-78 (1993). (Pubitemid 23030276)
34. Estrada, J. et al. The complete normalization of the adrenocortical function as the criterion of cure after transsphenoidal surgery for Cushing's disease. J. Clin. Endocrinol. Metab. 86, 5695-5699 (2001). (Pubitemid 33152610)
35. Esposito, F. et al. Clinical review: Early morning Cortisol levels as a predictor of remission after transsphenoidal surgery for Cushing's disease. J. Clin. Endocrinol. Metab. 91, 7-13 (2006). (Pubitemid 43069107)
36. Chen, J. C. et al. Transsphenoidal microsurgical treatment of Cushing disease: postoperative assessment of surgical efficacy by application of an overnight low-dose dexamethasone suppression test. J. Neurosurg. 98, 967-973 (2003). (Pubitemid 36460886)
37. Barbetta, L. et al. Assessment of cure and recurrence after pituitary surgery for Cushing's disease. Acta Neurochir. (Wien.) 143, 477-482 (2001). (Pubitemid 32477350)
38. Avgerinos, P. C. et al. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome. J. Clin. Endocrinol. Metab. 65, 906-913 (1987). (Pubitemid 17162639)
39. Castinetti, F. et al. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease. J. Clin. Endocrinol. Metab. 94, 1897-1903 (2009).
40. van Aken, M. O., de Herder, W. W., van der Lely, A. J., de Jong, F. H. & Lamberts, S. W. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease. Clin. Endocrinol. (Oxf.) 47, 145-149 (1997).
41. Pereira, A.M. et al. Long-term predictive value of postsurgical Cortisol concentrations for cure and risk of recurrence in Cushing's disease. J. Clin. Endocrinol. Metab. 88, 5858-5864 (2003). (Pubitemid 38033063)
42. Nunes, M. L. et al. Late-night salivary Cortisol for diagnosis of overt and subclinical Cushing's syndrome in hospitalized and ambulatory patients. J. Clin. Endocrinol. Metab. 94, 456-462 (2009).
43. Tani, Y. et al. Ectopic ACTH syndrome caused by bronchial carcinoid tumor indistinguishable from Cushing's disease. Endocr. J. 57, 679-686 (2010).
44. Valassi, E. et al. Delayed remission after transsphenoidal surgery in patients with Cushing's disease. J. Clin. Endocrinol. Metab. 95, 601-610 (2010).
45. Patil, C. G. et al. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Neurosurgery 63, 266-271 (2008).
46. Estrada, J. et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N. Engl. J. Med. 336, 172-177 (1997). (Pubitemid 27034962)
47. Littley, M. D. et al. Long-term follow-up of low-dose external pituitary irradiation for Cushing's disease. Clin. Endocrinol. (Oxf.) 33, 445-455 (1990). (Pubitemid 20290684)
48. Laws, E. R. Jr & Vance, M. L. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg. Clin. N. Am. 10, 327-336 (1999). (Pubitemid 29210653)
49. Sheehan, J. M., Vance, M. L, Sheehan, J. P., Ellegala, D. B. & Laws, E. R. Jr. Radiosurgery for Cushing's disease after failed transsphenoidal surgery. J. Neurosurg. 93, 738-742 (2000). (Pubitemid 32803394)
50. Colin, P. et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int. J. Radiat. Oncol. Biol. Phys. 62, 333-341 (2005). (Pubitemid 40704447)
51. Devin, J. K. et al. The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease. Stereotact. Funct. Neurosurg. 82, 254-262 (2004).
52. Levy, R. P. et al. Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients. Stereotact. Funct. Neurosurg. 57, 22-35 (1991).
53. Petit, J. H. et al. Proton stereotactic radiotherapy for persistent adrenocorticotropin-producing adenomas. J. Clin. Endocrinol. Metab. 93, 393-399 (2008). (Pubitemid 351246676)
54. Minniti, G. et al. Long-term follow-up results of postoperative radiation therapy for Cushing's disease. J. Neurooncol. 84, 79-84 (2007). (Pubitemid 47103447)
55. Castinetti, F. et al. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. Eur. J. Endocrinol. 156, 91-98 (2007). (Pubitemid 46553907)
56. Landolt, A. M. et al. Octreotide may act as a radioprotective agent in acromegaly. J. Clin. Endocrinol. Metab. 85, 1287-1289 (2000). (Pubitemid 32269387)
57. Feigl, G. C., Bonelli, C. M., Berghold, A. & Mokry, M. Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J. Neurosurg. 97 (Suppl.), 415-421 (2002). (Pubitemid 35424316)
58. Sheehan, J. P. et al., Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J. Neurosurg. 102, 678-691 (2005). (Pubitemid 43186673)
59. Brada, M. et al. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin. Endocrinol. (Oxf.) 38, 571-578 (1993). (Pubitemid 23168470)
60. Minniti, G., Traish, D., Ashley, S., Gonsalves, B. & Brada, M. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J. Clin. Endocrinol. Metab. 90, 800-804 (2005). (Pubitemid 40279200)
61. Nieman, L. K. Medical therapy of Cushing's disease. Pituitary 5, 77-82 (2002). (Pubitemid 36336012)
62. Schteingart, D. E. Drugs in the medical treatment of Cushing's syndrome. Expert Opin. Emerg. Drugs. 14, 661-671 (2009).
63. Sonino, N., Boscaro, M., Paoletta, A., Mantero, F. & Ziliotto, D. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients. Clin. Endocrinol. (Oxf.) 35, 347-352 (1991).
64. McCance, D. R., Ritchie, C. M., Sheridan, B. & Atkinson, A. B. Acute hypoadrenalism and hepatotoxicity after treatment with ketoconazole. Lancet 1, 573 (1987). (Pubitemid 17020775)
65. Tabarin, A. et al. Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome. Clin. Endocrinol. (Oxf.) 34, 63-69 (1991).
66. Verhelst, J. A. et al. Short and long-term responses to metyrapone in the medical management of 91 patients with Cushing's syndrome. Clin. Endocrinol. (Oxf.) 35, 169-178 (1991).
67. Gormley, M. J. et al. Cushing's syndrome in pregnancy - treatment with metyrapone. Clin. Endocrinol. (Oxf.) 16, 283-293 (1982). (Pubitemid 12168208)
68. Lindsay, J. R., Jonklaas, J., Oldfield, E. H. & Nieman, L. K. Cushing's syndrome during pregnancy: personal experience and review of the literature. J. Clin. Endocrinol. Metab. 90, 3077-3083 (2005). (Pubitemid 40686367)
69. Luton, J. P. et al., Treatment of Cushing's disease by o,p' DDD. Survey of 62 cases. N. Engl. J. Med. 300, 459-464 (1979). (Pubitemid 9134790)
70. Leiba, S. et al. The protracted effect of o,p'-DDD in Cushing's disease and its impact on adrenal morphogenesis of young human embryo. Ann. Endocrinol. (Paris) 50, 49-53 (1989). (Pubitemid 19063120)
71. Allolio, B. et al. Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome. Klin. Wochenschr. 66, 361-364 (1988).
72. Schulte, H. M., Benker, G., Reinwein, D., Sippell, W. G. & Allolio, P. Infusion of low dose etomidate: correction of hypercortisolemia in patients with Cushing's syndrome and dose-response relationship in normal subjects. J. Clin. Endocrinol. Metab. 70, 1426-1430 (1990).
73. Thorén, M., Adamson, U. & Sjöberg, H. E. Aminoglutethimide and metyrapone in the management of Cushing's syndrome. Acta Endocrinol. (Copenh.) 109, 451-457 (1985). (Pubitemid 15017164)
74. Dewis, P., Anderson, D. C., Bu'lock, D. E., Earnshaw, R. & Kelly, W. F. Experience with trilostane in the treatment of Cushing's syndrome. Clin. Endocrinol. (Oxf.) 18, 533-540 (1983). (Pubitemid 13089442)
75. Klibanski, A. Clinical practice. Prolactinomas. N. Engl. J. Med. 362, 1219-1226 (2010).
76. de Bruin, C., Feelders, R. A., Lamberts, S. W. & Hofland, L. J. Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome. Rev. Endocr. Metab. Disord. 10, 91-102 (2009).
77. Pivonello, R. et al. The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery. J. Clin. Endocrinol. Metab. 94, 223-230 (2009).
78. Godbout, A. et al. Cabergoline monotherapy in the long-term treatment of Cushing's disease. Eur. J. Endocrinol. 163, 709-716 (2010).
79. Schade, R., Andersohn, F.,Suissa,S., Haverkamp, W. & Garbe, E. Dopamine agonists and the risk of cardiac-valve regurgitation. N. Engl. J. Med. 356, 29-38 (2007). (Pubitemid 46041751)
80. Zanettini, R. et al. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N. Engl. J. Med. 356, 39-46 (2007). (Pubitemid 46041752)
81. Valassi, E., Klibanski, A. & Biller, B. M. Clinical Review: Potential cardiac valve effects of dopamine agonists in hyperprolactinemia. J. Clin. Endocrinol. Metab. 95, 1025-1033 (2010).
82. Ben-Shlomo, A. et al. Differential ligand-mediated pituitary somatostatin receptor subtype signaling: implications for corticotroph tumor therapy. J. Clin. Endocrinol. Metab. 94, 4342-4350 (2009).
83. Boscaro, M. et al. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (S0M230): a multicenter, phase II trial. J. Clin. Endocrinol. Metab. 94, 115-122 (2009).
84. Feelders, R. A. et al. Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease. N. Engl. J. Med. 362, 1846-1848 (2010).
85. Vilar, L. et al. Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease. Pituitary 13, 123-129 (2010).
86. Kreutzer, J. et al. No effect of the PPAR-gamma agonist rosiglitazone on ACTH or Cortisol secretion in Nelson's syndrome and Cushing's disease in vitro and in vivo. Clin. Neuropathol. 28, 430-439 (2009).
87. Castinetti, F. et al. Merits and pitfalls of mifepristone in Cushing's syndrome. Eur. J. Endocrinol. 160, 1003-1010 (2009).
88. Porterfield, J. R. et al. Surgery for Cushing's syndrome: an historical review and recent ten-year experience. World J. Surg. 32, 659-677 (2008).
89. Vella, A. et al. Laparoscopic adrenalectomy for adrenocorticotropin- dependent Cushing's syndrome. J. Clin. Endocrinol. Metab. 86, 1596-1599 (2001). (Pubitemid 32374909)
90. Chapuis, Y., Chastanet, S., Dousset, B. & Luton, J. P. Bilateral laparoscopic adrenalectomy for Cushing's disease. Br. J. Surg. 84, 1009 (1997).
91. Smith, PW. et al. Bilateral adrenalectomy for refractory Cushing disease: a safe and definitive therapy. J. Am. Coll. Surg. 208, 1059-1064 (2009).
92. Thompson, S. K. et al. Improved quality of life after bilateral laparoscopic adrenalectomy for Cushing's disease: a 10-year experience. Ann. Surg. 245, 790-794 (2007). (Pubitemid 46684110)
93. Nagesser, S. K. et al. Long-term results of total adrenalectomy for Cushing's disease. World J. Surg. 24, 108-113 (2000).
94. Thompson, G. B. et al. Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients. Surgery 122, 1132-1136 (1997). (Pubitemid 28016682)
95. Chow, J. T. et al. Bilateral laparoscopic adrenalectomy for corticotrophin-dependent Cushing's syndrome: a review of the Mayo Clinic experience. Clin. Endocrinol. (Oxf.) 68, 513-519 (2008). (Pubitemid 351388707)
96. Assalia, A. & Gagner, M. Laparoscopic adrenalectomy. Br. J. Surg. 91, 1259-1274 (2004). (Pubitemid 39331450)
97. Nelson, D. H. et al. ACTH-producing tumor of the pituitary gland. N. Engl. J. Med. 259, 161-164 (1958).
98. Assié, G. et al. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: a reappraisal of Nelson's Syndrome. J. Clin. Endocrinol. Metab. 92, 172-179 (2007). (Pubitemid 46067527)
99. De Tommasi, C., Vance, M. L., Okonkwo, D. O., Diallo, A. & Laws, E. R. Jr. Surgical management of adrenocorticotropic hormone-secreting macroadenomas: outcome and challenges in patients with Cushing's disease or Nelson's syndrome. J. Neurosurg. 103, 825-830 (2005). (Pubitemid 43194575)
100. Vik-Mo, E. O. et al. Gamma knife stereotactic radiosurgery of Nelson syndrome. Eur. J. Endocrinol. 160, 143-148 (2009).
101. Yanovski, J. A., Cutler, G. B. Jr, Chrousos, G. P. & Nieman, L. K. Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 269, 2232-2238 (1993). (Pubitemid 23120279)
102. Valassi, E. et al. Concomitant medication use can confound Interpretation of the combined dexamethasone-corticotropin releasing hormone test in Cushing's syndrome. J. Clin. Endocrinol. Metab. 94, 4851-4859 (2009).
103. Doppman, J. L. et al. Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. J. Comput. Assist Tomogr. 12, 728-735 (1988).
104. Hall, W. A., Luciano, M. G., Doppman, J. L., Patronas, N. J. & Oldfield, E. H. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann. Intern. Med. 120, 817-820 (1994). (Pubitemid 24140506)
105. Nieman, L. K. et al. The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. Ann. Intern. Med. 105, 862-867 (1986). (Pubitemid 17201760)
106. Bakiri, F. et al. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up. J. Endocrinol. Invest. 19, 572-580 (1996). (Pubitemid 26408097)
107. Knappe, U. J. & Lüdecke, D. K. Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease. Acta Neurochir. Suppl. 65, 31-34 (1996). (Pubitemid 126446155)
108. Cavagnini, F. & Pecori Giraldi, F. Epidemiology and follow-up of Cushing's disease. Ann. Endocrinol. (Paris) 62, 168-172 (2001).
109. Flitsch, J., Knappe, U. J. & Lüdecke, D. K. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease. Zentralbl Neurochir. 64, 6-11 (2003). (Pubitemid 36176302)
110. Salenave, S. et al. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. J. Clin. Endocrinol. Metab. 89, 3371-3376 (2004). (Pubitemid 38951906)
111. Atkinson, A. B., Kennedy, A., Wiggam, M. I., McCance, D. R. & Sheridan, B. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance. Clin. Endocrinol. (Oxf.) 63, 549-559 (2005). (Pubitemid 41626751)
112. Hofmann, B. M. & Fahlbusch, R. Treatment of Cushing's disease: a retrospective clinical study of the latest 100 cases. Front. Norm. Res. 34, 158-184 (2006). (Pubitemid 43265658)
113. Acebes, J. J., Martino, J., Masuet, C., Montanya, E. & Soler, J. Early post-operative ACTH and Cortisol as predictors of remission in Cushing's disease. Acta Neurochir. (Wien.) 149, 471-479 (2007).
114. Rollin, G., Ferreira, N. P. & Czepielewski, M. A. Prospective evaluation of transsphenoidal pituitary surgery in 108 patients with Cushing's disease. Arq. Bras. Endocrinol. Metabol. 51, 1355-1361 (2007).
115. Hofmann, B. M. et al. Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J. Neurosurg. 108, 9-18 (2008).
116. Prevedello, D. M. et al. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging. J. Neurosurg. 109, 751-759 (2008).
117. Fomekong, E., Maiter, D., Grandin, C. & Raftopoulos, C. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Clin. Neurol. Neurosurg. 111, 442-449 (2009).
118. Jagannathan, J. et al. Outcome of using the histological pseudocapsule as a surgical capsule in Cushing disease. J. Neurosurg. 111, 531-539 (2009).
119. Murayama, M. et al. Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation. J. Clin. Endocrinol. Metab. 75, 935-942 (1992).
120. Tsang, R. W. et al. Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother. Oncol. 41, 45-53 (1996). (Pubitemid 26396296)
121. Witt, T C., Kondziolka, D., Flickinger, J. C. & Lunsford, L. D. in Gamma knife radiosurgery for pituitary tumors (eds Lunsford, L. D., Kondziolka, D. & Flickinger, J. C.) 114-127 (Karger, Basel, 1998).
122. Kobayashi, T., Kida, Y. & Mori, Y. Gamma knife radiosurgery in the treatment of Cushing disease: long-term results. J. Neurosurg. 97, 422-428 (2002). (Pubitemid 35424317)
123. Jagannathan, J. et al. Gamma Knife surgery for Cushing's disease. J. Neurosurg. 106, 980-987 (2007). (Pubitemid 46871110)